Connect Biopharma Holdings Ltd. (CNTB)
NASDAQ · Healthcare
Connect Biopharma Holdings Ltd. Net Income 2023–2025
Connect Biopharma Holdings Ltd. annual/quarterly net income history and growth rate from 2023 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Connect Biopharma Holdings Ltd. net income for the quarter ending March 31, 2026 was -19.4 M, a 88.84% increase year-over-year.
- Connect Biopharma Holdings Ltd. net income for the twelve months ending March 31, 2026 was -59.8 M.
- Connect Biopharma Holdings Ltd. annual net income for 2025 was -55.5 M, a 255.00% increase from 2024.
- Connect Biopharma Holdings Ltd. annual net income for 2024 was -15.6 M, a 74.84% decrease from 2023.
- Connect Biopharma Holdings Ltd. annual net income for 2023 was -62.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Connect Biopharma Holdings Ltd. Net Income — FAQ
Connect Biopharma Holdings Ltd. (CNTB) net income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Connect Biopharma Holdings Ltd.'s net income?
Connect Biopharma Holdings Ltd. (CNTB) reported net income of -$55M for fiscal 2025.
Where can I see CNTB's net income history?
The chart and table above show Connect Biopharma Holdings Ltd.'s net income by year and by quarter, including the growth rate.